EP3719034 - METHOD FOR PREPARING COMPOSITION CONTAINING FACTOR 8 CAPABLE OF CONTROLLING CONTENT OF VON WILLEBRAND FACTOR (VWF) AND VON WILLEBRAND FACTOR [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 19.01.2024 Database last updated on 26.06.2024 | |
Former | Request for examination was made Status updated on 31.07.2020 | ||
Former | The international publication has been made Status updated on 04.05.2019 | Most recent event Tooltip | 22.04.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states Green Cross Holdings Corporation 107 Ihyeon-ro 30beon-gil Giheung-gu Yongin-si, Gyeonggi-do 16924 / KR | [2020/36] | Inventor(s) | 01 /
AHN, Jee Won B-902 11 Bangbaecheon-ro Seocho-gu Seoul 06693 / KR | 02 /
KO, Kwan Young 3-302 10-14 Yonggu-daero 2801beon-gil Suji-gu Yongin-si Gyeonggi-do 16865 / KR | 03 /
YOON, Jeong Hye 704-1107 49 Pureunsol-ro Suji-gu Yongin-si Gyeonggi-do 16874 / KR | 04 /
BAEK, Seung-Ho BA-501 19 Pyeongcheon-ro 751beon-gil Bucheon-si Gyeonggi-do 14495 / KR | 05 /
KIM, Min Jung 4F. 48-1 Teheran-ro 22-gil Gangnam-gu Seoul 06245 / KR | 06 /
YEO, Geun Hye No.302 16 Gumi-ro Bundang-gu Seongnam-si Gyeonggi-do 13638 / KR | 07 /
LIM, Jung-Ae No.202 14 Munin-ro 54beon-gil Suji-gu Yongin-si Gyeonggi-do 16828 / KR | 08 /
KIM, Soo-kwang 439-405 33 Cheongmyeongbuk-ro Yeongtong-gu Suwon-si Gyeonggi-do 16709 / KR | [2020/36] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [N/P] |
Former [2020/36] | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | Application number, filing date | 18870991.9 | 26.10.2018 | [2020/36] | WO2018KR12820 | Priority number, date | KR20170141444 | 27.10.2017 Original published format: KR 20170141444 | [2020/36] | Filing language | KO | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2019083319 | Date: | 02.05.2019 | Language: | KO | [2019/18] | Type: | A2 Application without search report | No.: | EP3719034 | Date: | 07.10.2020 | Language: | EN | [2020/41] | Search report(s) | International search report - published on: | KR | 20.06.2019 | (Supplementary) European search report - dispatched on: | EP | 25.06.2021 | Classification | IPC: | C07K14/755, C07K1/18, B01D15/36, B01D15/18, B01D15/24 | [2021/30] | CPC: |
B01D15/362 (EP,KR,US);
C07K14/755 (EP,KR);
C07K1/18 (KR,US);
A61K38/37 (EP,US);
B01D15/1871 (EP);
B01D15/24 (EP);
B01D15/363 (EP,KR,US)
(-)
|
Former IPC [2020/36] | C07K14/755, C07K1/18, B01D15/36 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/36] | Title | German: | VERFAHREN ZUR HERSTELLUNG EINER ZUSAMMENSETZUNG MIT FAKTOR-8 ZUR KONTROLLE DER KONZENTRATION VON VON WILLEBRAND-FAKTOR (VWF) UND VON WILLEBRAND-FAKTOR | [2020/36] | English: | METHOD FOR PREPARING COMPOSITION CONTAINING FACTOR 8 CAPABLE OF CONTROLLING CONTENT OF VON WILLEBRAND FACTOR (VWF) AND VON WILLEBRAND FACTOR | [2020/36] | French: | PROCÉDÉ DE PRÉPARATION D'UNE COMPOSITION CONTENANT UN FACTEUR 8 CAPABLE DE CONTRÔLER LA TENEUR EN FACTEUR DE VON WILLEBRAND (VWF) ET FACTEUR DE VON WILLEBRAND | [2020/36] | Entry into regional phase | 14.05.2020 | Translation filed | 14.05.2020 | National basic fee paid | 14.05.2020 | Search fee paid | 14.05.2020 | Designation fee(s) paid | 14.05.2020 | Examination fee paid | Examination procedure | 14.05.2020 | Examination requested [2020/36] | 10.01.2022 | Amendment by applicant (claims and/or description) | 18.01.2024 | Despatch of a communication from the examining division (Time limit: M04) | 19.04.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 21.10.2020 | Renewal fee patent year 03 | 20.10.2021 | Renewal fee patent year 04 | 18.10.2022 | Renewal fee patent year 05 | 23.10.2023 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]EP0600480 (SCLAVO SPA [IT], et al) [A] 1-12 * example .; claim - *; | [XA]EP0934748 (HEMASURE DENMARK AS [DK]) [X] 13-15 * example -; claim - * [A] 1-12; | [X] - JOSIC D ET AL, "PURIFICATION OF FACTOR VIII AND VON WILLEBRAND FACTOR FROM HUMAN PLASMA BY ANION-EXCHANGE CHROMATOGRAPHY", JOURNAL OF CHROMATOGRAPHY B, ELSEVIER SCIENCE PUBLISHERS, NL, (19940101), vol. 662, no. 2, doi:10.1016/0378-4347(94)00204-5, ISSN 0378-4347, pages 181 - 190, XP009025613 [X] 13-15 * 2.4. Purification of factor VIII * DOI: http://dx.doi.org/10.1016/0378-4347(94)00204-5 | International search | [A]EP0934748 (HEMASURE DENMARK AS [DK]) [A] 1-20 * 1, 3, 4; [0048], [0080]-[0084 *; | [A]KR20100058520 (LFB BIOTECHNOLOGIES [FR]) [A] 1-20 * 1, 8, 9; [0095], [0157] *; | [A]WO2010082184 (KEDRION SPA [IT], et al)[A] 1-20; | [A]WO2015021423 (BIOGEN IDEC INC [US]) [A] 1-20; | [A]WO2016162310 (GE HEALTHCARE BIOPROCESS R&D AB [SE]) [A] 1-20 | by applicant | US4361509 | US4764369 | - E.G.D. TUDDENHAM et al., Journal of Laboratory Clinical Medicine, (19790000), vol. 93, page 40 | - D.E.G. AUSTEN, British Journal of Haematology, (19790000), vol. 43, page 669 |